NCT03875755View on ClinicalTrials.gov

Myo-inositol for Reduction of Insulin Therapy in Gestational Diabetes Mellitus

NARecruitingINTERVENTIONAL
Enrollment

1,080

Participants

Timeline

Start Date

March 4, 2020

Primary Completion Date

November 4, 2024

Study Completion Date

March 4, 2025

Conditions
Gestational Diabetes Mellitus
Interventions
DIETARY_SUPPLEMENT

Myo Inositol

One soft gel capsule containing MI 600 mg and folic acid 200 μg twice a day, until delivery.

OTHER

Placebo

One soft gel capsule of placebo (folic acid 200 μg) twice a day until delivery.

Trial Locations (1)

93000

RECRUITING

Hôpital Avicenne, Bobigny

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER